Kailera Therapeutics · 5 days ago
Manager, Patient Safety and Pharmacovigilance Operations
Kailera is committed to developing therapies that transform lives and enhance health. The Manager of Patient Safety and Pharmacovigilance Operations will oversee safety vendor activities, ensuring compliance with regulations and quality standards while promoting operational excellence within the team.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Act as a subject matter expert on emerging global guidelines and regulations, assessing impact on existing procedures, and recommending updates
Support PSPV Operations in the development and maintenance of safety vendor documentation (e.g., SMP, SAE/AESI, Pregnancy Reporting forms, etc.)
Responsible for the oversight of the safety vendor ICSR case processing and reporting activities (e.g., ensuring high quality and compliant case processing and submission activities including narrative writing, coding (MedDRA), query resolution, reports generation, study closure, etc.), SAE Reconciliation support, and safety vendor metrics (e.g., KPIs and KQIs, etc.) as defined in the SMP
Act as primary day-to-day liaison with the safety vendor project manager and team leads to ensure efficient case workflow to meet PSPV and alliance partner obligations
Support in-line and/or retrospective case quality review (e.g., to assess coding accuracy, narrative completeness, data integrity, regulatory compliance, etc.)
Develop and maintain a robust and easily navigable PSPV SharePoint repository
Document, track, and escalate issues or quality trends as per process and the PV Quality Agreement. Identify process or quality gaps and contribute to effective, stage appropriate, and compliant solutions
Collaborate with the safety vendor to provide timely delivery of internal and external safety database data extract requests and support safety database activities (e.g., database updates, processes, new study configurations, access issue escalations, case processing conventions, system implementation/transitions, etc.)
Contribute to controlled document development and maintenance (e.g., SOPs, WIs, SAE/pregnancy forms, SMPs, etc.) and support inspection readiness activities
Support PSPV Aggregate reporting activities (e.g., signal detection, DSUR, risk management, literature review, etc.), as required
Promote a culture of compliance, operational excellence, and continuous improvement within the PSPV team and ensure effective communication with internal and external shareholders
Empowered to drive and/or support initiatives to standardize procedures, improve efficiency, and manage change within operations and PSPV as a whole
Support TMF filing activities
Participate in internal and external team meetings (e.g., clinical study team meetings, safety vendor governance activities, alliance meetings, etc.)
Qualification
Required
Minimum of 6+ years of experience in Drug Safety/Pharmacovigilance Operations within the pharmaceutical or biotechnology industry
Working knowledge of global PV regulations, including FDA and ICH guidelines
Demonstrated working knowledge of safety databases (e.g., Argus), especially reports generation, PV dashboard, etc
Demonstrated ability to work collaboratively in a fast-paced, cross-functional, and matrixed environment with strong organizational, time management, and project prioritization skills
Excellent verbal and written communication and interpersonal skills
Prior PV Operations and safety vendor management experience required
Adaptable to changing priorities
Proficient computer skills, including Microsoft Word and Excel
Must be able and willing to travel on occasion
Bachelor's degree in Life Sciences (or equivalent experience) or a related field required. (BS, RN, preferred)
Preferred
Prior PV audit and/or inspection experience a plus
Safety database data retrieval experience preferred
Benefits
Comprehensive health coverage
Flexible time off
Paid holidays
Year-end shutdown
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants
Company
Kailera Therapeutics
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Funding
Current Stage
Growth StageTotal Funding
$1BKey Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M
Leadership Team
Recent News
2026-01-05
2025-12-24
2025-12-17
Company data provided by crunchbase